ASCO: Cancer Drug Showdown
Ariad, Pharmacyclics, and Johnson & Johnson present impressive data. Clovis battles with AstraZeneca.
The 3 Biggest Biotech Crashes in May
Here's what you need to know about tumbling shares in Insys, Clovis, and Aegerion.
Why Clovis Oncology Inc. Shares Were Clobbered Again
Clovis shares take a beating following ASCO data and analyst commentary. Find out what investors' best course of action is going forward.
Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology
Vanda Pharmaceuticals, Prosensa, and Clovis Oncology could all loom large in health care headlines this morning. Here’s why.